Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-10-009432
Filing Date
2010-03-24
Accepted
2010-03-24 16:02:03
Documents
1
Period of Report
2010-03-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7376
  Complete submission text file 0001127602-10-009432.txt   9376
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 10701876